Pharsight

Drugs that contain Sodium Phenylbutyrate

1. Olpruva patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11202767 ACER Methods of treating urea cycle disorders and maple syrup urine disease
Oct, 2036

(12 years from now)

US11433041 ACER Palatable compositions including sodium phenylbutyrate and uses thereof
Oct, 2036

(12 years from now)

US11154521 ACER Palatable compositions including sodium phenylbutyrate and uses thereof
Oct, 2036

(12 years from now)

Market Authorisation Date: 22 December, 2022

Treatment: Treatment of a urea cycle disorder involving deficiencies of carbamylphosphate synthetase, ornithine transcarbamylase, or argininosuccinic acid synthetase

Dosage: FOR SUSPENSION;ORAL

More Information on Dosage

OLPRUVA family patents

Family Patents